Background
Elevated right atrial (RA) pressure is a risk factor for mortality
and RA size is prognostic of adverse outcomes in pulmonary hypertension
(PH). There is limited data on phasic RA function (reservoir, conduit, and
pump) in pediatric PH. We sought to evaluate 1) the RA function in pediatric
PH patients compared to controls, 2) compare the RA deformation indices with
Doppler indices of diastolic dysfunction, functional capacity, biomarkers,
invasive hemodynamics, and right ventricular (RV) functional indices, and 3)
evaluate the potential of RA deformation indices to predict clinical
outcomes.
Methods and Results
Sixty-six PH patients (mean age 7.9 ±4.7 years) were compared
with 36 controls (7.7 ±4.4 years). RA and RV deformation indices
were obtained using two-dimensional speckle tracking (2DCPA, TomTec). RA
strain, strain rates, emptying fraction (EF), and RV longitudinal strain
(LS) were measured. RA function was impaired in PH patients versus controls
(p<0.001). There were significant associations between RA function with
invasive hemodynamics (p<0.01). RA reservoir, pump function, the rate of
RA filling, and atrial minimum volume predicted adverse clinical outcomes
(HR (CI) 0.15 (0.03–0.73), p<0.01; 0.05 (0.003–0.43), p
<0.004; 0.04 (0.006–0.56), p<0.01; 8.6 (1.6–37.2),
p<0.01 respectively).
Conclusions
RA deformation properties are significantly altered in pediatric PH patients. Progressive worsening of RA reservoir and conduit functions are related to changes in RV diastolic dysfunction. RA reservoir function, pump function, the rate of atrial filling, and atrial minimum volume emerged as outcome predictors in pediatric PH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.